4.8 Article

Structure- based design of nanobodies that inhibit seeding of Alzheimer's patient-extracted tau fibrils

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics

Wael Alata et al.

Summary: The study demonstrates the development of technologies targeting the blood-brain barrier to allow drugs to enter the brain. Through in vitro and in vivo experiments, the researchers showed the effectiveness of these technologies and their potential in pain treatment.

FASEB JOURNAL (2022)

Article Multidisciplinary Sciences

De novo designed protein inhibitors of amyloid aggregation and seeding

Kevin A. Murray et al.

Summary: Neurodegenerative diseases are characterized by the accumulation of aggregated proteins, and inhibiting the formation of these aggregates is a potential therapeutic strategy. Using de novo protein design, researchers have developed a library of mini-protein inhibitors that specifically target the amyloid structures of tau, Aβ, and α Syn. These inhibitors show promising results in preventing aggregation and rescuing motor deficits in animal models of PD and AD.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

Proliferation of Tau 304-380 Fragment Aggregates through Autocatalytic Secondary Nucleation

Diana C. Rodriguez Camargo et al.

Summary: The study reveals the fibril formation mechanism of the tau protein fragment 304-380 under physiological conditions, showing that primary nucleation is slow and secondary processes dominate aggregation. Results from mass spectrometry measurements verify that small aggregates are generated from monomers through secondary nucleation, providing insights for therapeutic interventions in Alzheimer's disease targeting tau forms.

ACS CHEMICAL NEUROSCIENCE (2021)

News Item Biotechnology & Applied Microbiology

Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating

Asher Mullard

Summary: A new wave of tau-targeted agents is being tested in clinical trials, aiming to avoid the negative outcomes seen in the first-in-class trial of a tau-targeted antibody.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Multidisciplinary Sciences

Structure-based classification of tauopathies

Yang Shi et al.

Summary: The structures of tau filaments from different tauopathies vary, allowing for a hierarchical classification of these diseases. Some tauopathies share similar filament folds, while others have distinct folding patterns.

NATURE (2021)

Review Biotechnology & Applied Microbiology

Strategies for delivering therapeutics across the blood-brain barrier

Georg C. Terstappen et al.

Summary: The blood-brain barrier presents a challenge for delivering therapeutics to the central nervous system, particularly for biopharmaceuticals. Non-invasive approaches have been developed to help overcome this challenge, with increasing research efforts focusing on technologies to deliver therapeutics to the CNS, some of which have entered clinical testing. Developing effective strategies for crossing the blood-brain barrier is crucial for treating CNS disorders, with a particular emphasis on non-invasive methods such as receptor-mediated transcytosis and the use of neurotropic viruses, nanoparticles, and exosomes.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Multidisciplinary Sciences

Defining the epitope of a blood-brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor

Joey Sheff et al.

Summary: HDX-MS and NMR studies revealed that the interaction between IGF1R and VHH-IR5 sdAb is mainly located in the α-CT helix region, while the binding with IGF-1 induces global conformational shifts in multiple domains.

SCIENTIFIC REPORTS (2021)

Article Immunology

Immunogenicity Risk Profile of Nanobodies

Chloe Ackaert et al.

Summary: The study assessed the immunogenicity risk profile of two Nanobodies in phase II clinical trials and found that monomeric Nbs have a low immunogenicity risk profile, indicating their potential for future clinical applications.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Medicine, General & Internal

The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease

Robert Steinbrook

JAMA INTERNAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains

Tamta Arakhamia et al.

Article Multidisciplinary Sciences

Novel tau filament fold in corticobasal degeneration

Wenjuan Zhang et al.

NATURE (2020)

Review Biochemical Research Methods

Recombinant expression of nanobodies and nanobody-derived immunoreagents

Ario de Marco

PROTEIN EXPRESSION AND PURIFICATION (2020)

Article Biochemistry & Molecular Biology

Performance and Its Limits in Rigid Body Protein-Protein Docking

Israel T. Desta et al.

STRUCTURE (2020)

Article Multidisciplinary Sciences

Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules

Benjamin Falcon et al.

NATURE (2019)

News Item Biotechnology & Applied Microbiology

Nanobody approval gives domain antibodies a boost

Chris Morrison

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Biochemistry & Molecular Biology

Structure-based inhibitors halt prion-like seeding by Alzheimer's disease?and tauopathy?derived brain tissue samples

Paul Matthew Seidler et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Multidisciplinary Sciences

Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis

Matthias Schmidt et al.

NATURE COMMUNICATIONS (2019)

Article Chemistry, Multidisciplinary

Structure-based inhibitors of tau aggregation

P. M. Seidler et al.

NATURE CHEMISTRY (2018)

Review Neurosciences

Prion-like Spreading in Tauopathies

Jacob I. Ayers et al.

BIOLOGICAL PSYCHIATRY (2018)

Article Multidisciplinary Sciences

Structures of filaments from Pick's disease reveal a novel tau protein fold

Benjamin Falcon et al.

NATURE (2018)

Editorial Material Multidisciplinary Sciences

NEURODEGENERATION Taming tangled tau

David S. Eisenberg et al.

NATURE (2017)

Article Multidisciplinary Sciences

Cryo-EM structures of tau filaments from Alzheimer's disease

Anthony W. P. Fitzpatrick et al.

NATURE (2017)

Review Neurosciences

What is the evidence that tau pathology spreads through prion-like propagation?

Amrit Mudher et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)

Review Medicine, Research & Experimental

The amyloid hypothesis of Alzheimer's disease at 25years

Dennis J. Selkoe et al.

EMBO MOLECULAR MEDICINE (2016)

Article Cell Biology

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

Matthew R. Brier et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Multidisciplinary Sciences

Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins

Pietro Sormanni et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Biochemistry & Molecular Biology

The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology

Maria del Carmen Cardenas-Aguayo et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Article Chemistry, Multidisciplinary

Probing the N-Terminal β-Sheet Conversion in the Crystal Structure of the Human Prion Protein Bound to a Nanobody

Romany N. N. Abskharon et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Review Biochemistry & Molecular Biology

Nanobodies: Natural Single-Domain Antibodies

Serge Muyldermans

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)

Article Biochemical Research Methods

NIH Image to ImageJ: 25 years of image analysis

Caroline A. Schneider et al.

NATURE METHODS (2012)

Article Multidisciplinary Sciences

Structure-based design of conformation- and sequence-specific antibodies against amyloid β

Joseph M. Perchiacca et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Multidisciplinary Sciences

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

Cristian A. Lasagna-Reeves et al.

SCIENTIFIC REPORTS (2012)

Article Chemistry, Multidisciplinary

Macrocyclic β-Sheet Peptides That Inhibit the Aggregation of a Tau-Protein-Derived Hexapeptide

Jing Zheng et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)

Article Neurosciences

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice

Cristian A. Lasagna-Reeves et al.

MOLECULAR NEURODEGENERATION (2011)

Article Multidisciplinary Sciences

Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation

Stuart A. Sievers et al.

NATURE (2011)

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemical Research Methods

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Paul D. Adams et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)

Article Neurosciences

Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model

Allal Boutajangout et al.

JOURNAL OF NEUROSCIENCE (2010)

Article Biochemistry & Molecular Biology

OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding

R. J. Pantazes et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2010)

Article Cell Biology

Transmission and spreading of tauopathy in transgenic mouse brain

Florence Clavaguera et al.

NATURE CELL BIOLOGY (2009)

Article Chemistry, Multidisciplinary

Phaser crystallographic software

Airlie J. McCoy et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)

Article Multidisciplinary Sciences

Atomic structures of amyloid cross-β spines reveal varied steric zippers

Michael R. Sawaya et al.

NATURE (2007)

Article Multidisciplinary Sciences

Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure

M von Bergen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)